Skip to main content
FinSpry Logo
FinSpry
BWAY logo
BWAY
(NASDAQ)
BrainsWay Ltd.
$13.57-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BrainsWay (BWAY) Stock Price & Financial Analysis

BrainsWay Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.29 - $13.74
52-Week High$18.18
52-Week Low$7.84
Open$13.65
Volume248.10K
Average Volume (3M)248.10K
Market Cap265.63M
Shares Outstanding19.57M
P/E Ratio (TTM)42.55
Forward P/E21.27
Price to Sales (P/S)5.41
Price to Book (P/B)3.79
EV/EBITDA20.87
Revenue (TTM)49.09M
Net Income (TTM)6.25M
Free Cash Flow (TTM)18.34M
EPS (TTM)$0.32
Profit Margin12.73%
Operating Margin5.78%
Return on Equity (ROE)8.92%
Debt to Equity0.10
50-Day MA$12.43
200-Day MA$13.49
52-Week Change47.77%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BrainsWay

What is the current stock price for BWAY?

As of the latest trading session, BWAY stock trades at $13.57. The 52-week range is $7.84–$18.18, with a day range of $13.29–$13.74.

What is the P/E ratio for BWAY?

BrainsWay's trailing P/E ratio is 42.5, meaning investors pay $42.5 for every $1 of annual earnings. The forward P/E is 21.3, reflecting analyst expectations for future earnings. BrainsWay operates in the Healthcare sector.

Does BWAY pay dividends?

BrainsWay does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BWAY?

Based on 2 analysts, the consensus for BWAY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BWAY?

BrainsWay's market capitalization is $265.6M, classifying it as a micro-cap company. BrainsWay operates in the Healthcare sector within the Medical Devices industry.